Picture of Becton Dickinson and Co logo

BDXB Becton Dickinson and Co News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Becton Dickinson up on upbeat FY23 forecast

** Shares of medical device maker Becton Dickinson and Co
 BDX.N  up 1.4% at $257.30 
    ** Co posts Q1 revenue of $4.59 bln, beating analysts'
average estimate of $4.52 bln, per Refinitiv data
    ** Reports Q1 adj. profit of $2.98/shr vs mean est.
$2.68/shr - Refinitiv 
    ** Sees FY23 adj profit in range $12.07/shr-$12.32/shr,
above mean est. of $11.95/shr - Refinitiv  
    ** Sees FY23 rev. in range $19.1 bln-$19.3 bln, above mean
est. $18.82 bln - Refinitiv 
    ** Stock has risen 3% in last 12 months
 (Reporting by Aditya Samal)
 ((Aditya.Samal@thomsonreuters.com;))

Recent news on Becton Dickinson and Co

See all news